Latest Options News

Sunshine Metals has increased its Liontown shallow gold resource by 14% to 108,000 ounces, advancing its pathway to near-term production in 2026. High-grade drilling results at the Sybil prospect and new VMS targets further strengthen the company’s exploration outlook.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.

Altair Minerals has confirmed a 1km southward extension of its South Oko gold soil anomaly, unveiling three open targets and setting the stage for maiden drilling. Meanwhile, its Olympic Domain copper-gold project remains a strategic focus amid ongoing commercial talks with BHP.

Green & Gold Minerals reports compelling high-grade silver alongside gold at Mt Wandoo, boosting the Chillagoe project's resource potential and advancing mining study prospects.

Beam Communications has received a US$9.03 million lump-sum payment from Roadpost, fully resolving its Zoleo divestment and dispute. This upfront cash injection accelerates value realisation and clears the way for Beam to focus on its core satellite communications business.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.

Tlou Energy progresses its Lesedi Power Project in Botswana, integrating gas-fired and solar power for a modular data centre, while navigating operational challenges and funding delays.

Ragusa Minerals has significantly expanded its Purple Pansy Manganese-Gold Project in Arizona by acquiring 201 additional tenements, enhancing its strategic landholding and exploration potential in a critical minerals hotspot.

Atomos Limited has reported a robust Q2 FY26 with a 44% jump in revenue and its second straight EBITDA-positive quarter, signaling a promising turnaround. The company’s strategic product launches and debt reduction efforts underpin an optimistic outlook for the second half of the fiscal year.

Botanix Pharmaceuticals reported a robust 28% increase in net revenue for Sofdra in Q2 FY26, driven by a 24% rise in prescriptions and a growing US sales team. The company maintains a strong cash position while navigating higher operating costs.

Fitzroy River Corporation reported steady royalty income for the December 2025 quarter, while advancing key projects including a $40 million funding campaign for the Rafael Gas Project and a $150 million equity raise for Snowy River Gold development.

Desert Metals Limited has completed the second tranche of its placement, raising a total of $1.25 million through new shares and options issued to investors and its lead manager.